To disseminate the findings generated in VALUE-Dx by using various forms of communication and educational activities and publications at all levels of stakeholder platforms to promote their uptake and implementation in daily clinical practice and policy
To develop innovative, effective ways to disseminate information for creating awareness of optimal diagnosis and prognosis of CA-ARTI to prevent unnecessary prescription and use of antibiotics, to improve coverage with antibiotics, and thus limit antibiotic resistance and associated health and socioeconomic impacts
To develop and to tailor materials to support the adoption of CA-ARTI-Dx in European community care settings
https://www.value-dx.eu/wp-content/uploads/2023/03/FqMsGbZWYAAkll6.jpg383680Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2023-03-02 09:27:312023-03-02 09:27:31VALUE-Dx paper BJGP Number 1 Most Read Article
https://www.value-dx.eu/wp-content/uploads/2019/07/shutterstock_1030079398.jpg40006000Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2022-11-23 15:25:492022-11-23 15:47:10VALUE-Dx gives recommendations for CA-ARTI diagnostics in new report
Read our interview with PhD student Juan Pablo Rodriguez Ruiz at the Laboratory of Medical Microbiology at the University of Antwerp. He discusses his work with Work Package 2 within Value-Dx, his future tasks and more.
https://www.value-dx.eu/wp-content/uploads/2022/10/Profile-picture-2-Juan-Pablo-scaled-e1665397645702.jpg9141078Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2022-10-10 10:04:332022-10-10 11:32:03Interview with PhD student Juan Pablo Rodriguez Ruiz